7,557
Participants
Start Date
January 31, 2002
Primary Completion Date
April 29, 2020
Study Completion Date
April 29, 2020
No intervention
Kidney recipients aged over 18 and of all sexes recruited from 2002 in European and North American centers, who have eGFR follow-up and data from protocol and for cause biopsies available for allograft survival assessment; RCT conducted over the past 20 years with available data on protocol biopsy within the first year and follow up clinical, biological and histological data.
Department of Nephrology and Renal Transplantation, University Hospitals Leuven, Leuven
Kidney Transplant Department, Necker Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France;, Paris
Department of Surgery, Johns Hopkins University School of Medicine, Baltimore
Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse
Centre Hospitalier Universitaire de Nantes, Nantes
William J. von Liebig Center for Transplantation and Clinical Regeneration, Rochester
Department of Transplantation, Nephrology and Clinical Immunology, Hospices Civils de Lyon, Lyon
Kidney Transplant Department, Saint-Louis Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France ;, Paris
Department of Transplantation, Nephrology and Clinical Immunology, Hôpital Foch, Suresnes, France, Suresnes
Virginia Commonwealth University School of Medicine, Richmond
Paris Translational Research Center for Organ Transplantation
OTHER